Activated SALL4 has been found in HCC with high metabolic activity, which displays the features of poor survival, the strongest stem cell signature, high genomic instability, and low potential for benefiting from immunotherapy (Jung et al. 2022). This evidence concerns the gene SALL4 and hepatocellular carcinoma.